Clinical Trials
- Thyroid and Other Endocrine Cancers, Gynecological Cancers
Endometrium and Metabolism
- Gynecological Cancers
A Phase II Evaluation of Afatinib
- Ages18 years and younger
- GenderFemale only
- Gynecological Cancers
A Randomized Phase 2 Study of CBX 12 in Subjects With Platinum Resistant or Refractory Ovarian Cancer
- Ages18 years - 99 years
- GenderFemale only
- Gynecological Cancers
A Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian Cancer
- GenderFemale only